GlaxoSmithKline (NYSE:GSK) has agreed to market some of its over-the-counter brands in Europe to Omega Pharma.
Belgium-based Omega Pharma is paying $614 million for brands such as stomach antacid Zantac and Nytol cold and allergy medicine .
Part of the deal includes transferring GSK’s Herrenberg, Germany factory to Omega Pharma.
via bizjournals.com
No comments:
Post a Comment